{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:42:48Z","timestamp":1793040168344,"version":"4.5.0"},"reference-count":25,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Vet Comparative Oncology"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The most commonly utilized protocols to treat lymphoma in cats employ vincristine, cyclophosphamide and prednisone; with additional drugs sometimes used including L\u2010asparaginase and doxorubicin. Medical records were reviewed for 55 cats with alimentary lymphoma treated with a novel multiagent protocol using prednisolone, L\u2010asparaginase, doxorubicin, vinblastine instead of vincristine, a higher dosage of cyclophosphamide and oral procarbazine (VAPC protocol). Outcomes evaluated were response to therapy, toxicity and progression\u2010free survival (PFS). Grade 3 or 4 neutropenia was the most common treatment\u2010related reason for chemotherapy dosage adjustment, occurring in 8 of 52 cats receiving vinblastine, 7 of 55 cats receiving cyclophosphamide and 1 of 40 cats receiving doxorubicin, but febrile neutropenia was identified in only two cats. Of 38 cats receiving chemotherapy for measurable disease, 26 (68.4%) achieved complete response (CR). Three cats achieved a partial response and 9 cats failed to achieve a remission. There were no identified factors influencing whether a cat was likely to achieve CR. For all 55 cats (including those receiving chemotherapy and surgery), median PFS was 184\u2009days with 1, 2 and 3\u2010year survival rates of 35.4%, 26.5% and 26.5%, respectively. On multivariate analysis, 40 cats that achieved CR had a median survival time of 341\u2009days (78\u2009days for PR, 45\u2009days for NR); PFS times were also significantly affected by lymphocyte:monocyte L:M ratio (&gt;3.4\u2009=\u2009700\u2009days vs. \u22643.4\u2009=\u2009126\u2009days) and B\u2010cell versus T\u2010cell phenotype (220\u2009days vs. 42\u2009days, respectively).<\/jats:p>","DOI":"10.1111\/vco.12958","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T08:55:30Z","timestamp":1703753730000},"page":"106-114","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Treatment of feline intermediate to high\u2010grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the <scp>VAPC<\/scp> combination chemotherapy protocol (2017\u20132021)"],"prefix":"10.1111","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8402-4100","authenticated-orcid":false,"given":"Antony Stewart","family":"Moore","sequence":"first","affiliation":[{"name":"Veterinary Oncology Consultants  Lake Innes New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Erica","family":"Frimberger","sequence":"additional","affiliation":[{"name":"Veterinary Oncology Consultants  Lake Innes New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,12,28]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2005.tb02703.x"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1998.tb02134.x"},{"key":"e_1_2_9_4_1","first-page":"696","article-title":"Treatment and prognostic factors in lymphoma in cats:104 cases(1977\u20101981)","volume":"194","author":"Mooney SC","year":"1989","journal-title":"J Am Vet Med Assoc"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-0813.1998.tb12300.x"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.2460\/javma.2005.227.1118"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X20984363"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2002.tb02352.x"},{"key":"e_1_2_9_9_1","first-page":"166","article-title":"Treatment of lymphoma and leukemia with cyclophosphamide, vincristine, and prednisone: II. Treatment of cats","volume":"19","author":"Cotter SM","year":"1983","journal-title":"J Am Anim Hosp Assoc"},{"key":"e_1_2_9_10_1","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2460\/javma.1995.207.12.1593","article-title":"Alimentary lymphoma in cats: 28 cases (1988\u20101993)","volume":"207","author":"Mahony O","year":"1995","journal-title":"J Am Vet Med Assoc"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2001.tb01243.x"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2007.tb03018.x"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1996.tb02083.x"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X221101533"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.12006"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X19841916"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2018.10.003"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2020.105450"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/vco.283"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.07.045120"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2008.0057.x"},{"key":"e_1_2_9_22_1","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2460\/javma.1998.213.08.1144","article-title":"Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993\u20101997)","volume":"213","author":"Zwahlen CH","year":"1998","journal-title":"J Am Vet Med Assoc"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2007.0031.x"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2006.tb02868.x"},{"key":"e_1_2_9_25_1","first-page":"1095","article-title":"Prognostic role of lymphocyte to monocyte ratio in feline high\u2010grade lymphomas","volume":"62","author":"Tagawa M","year":"2021","journal-title":"Can Vet J"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/vsu.13281"}],"container-title":["Veterinary and Comparative Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vco.12958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T06:33:52Z","timestamp":1707719632000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vco.12958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,28]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1111\/vco.12958"],"URL":"https:\/\/doi.org\/10.1111\/vco.12958","archive":["Portico"],"relation":{},"ISSN":["1476-5810","1476-5829"],"issn-type":[{"value":"1476-5810","type":"print"},{"value":"1476-5829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,28]]},"assertion":[{"value":"2023-08-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}